Eli Lilly and Company (LLY · NYSE)
LLY · MARKET VIEW
Market view · as of Aug 24, 2026
Revenue (TTM)
$79.67B
+47.7% YoY
Gross margin
83.4%
EPS (latest q)
$8.38
vs $6.01 est · beat
52-wk position
95.8%
-1.9% vs 52w high · +5.1% 1mo
Price (last ~year)
Eli Lilly and Company (LLY) maintains a $1.12 trillion market capitalization, supported by 47.7% year-over-year revenue growth and four consecutive quarterly earnings beats. The pharmaceutical manufacturer reported $22.97 billion in revenue for the quarter ending June 30, 2026, alongside an 83.4% gross margin and 54.2% operating margin. Shares are trading at $1255.40, reflecting a 16.1% increase over the last three months and a P/E ratio of 42.2.
Valuation
- Market cap
- $1.12T
- P/E
- 42.2
- PEG
- 1.579
- P/B
- 33.03
- P/S
- 14.05
- EV/EBITDA
- 27.93
- Beta
- 0.506
- Analyst target
- $1315.04
Quality & returns
- Gross margin
- 83.4%
- Operating margin
- 54.2%
- Profit margin
- 33.5%
- ROE
- 102.3%
- ROA
- 20.4%
Price movement
- Last
- $1255.40
- 1-month
- +5.1%
- 3-month
- +16.1%
- RSI (14)
- 70
- vs SMA200
- +19.6%
- 52-wk position
- 95.8% -1.9% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $22.97B | $8.98B | $7.09B | $9.25B |
| 2026-03-31 | $19.80B | $8.85B | $7.40B | $9.69B |
| 2025-12-31 | $19.29B | $8.78B | $6.64B | $8.39B |
| 2025-09-30 | $17.60B | $8.39B | $5.58B | $7.88B |
Recent news
- Neutral Danaher vs. Intuitive Surgical: Is Recovery or Innovation the Better Long-Term Bet? · 2026-08-23
- Neutral Kiltearn Partners LLP Purchases Shares of 345,471 CVS Health Corporation $CVS · 2026-08-23
- Somewhat-Bullish Westpac Banking Corp Makes New Investment in CVS Health Corporation $CVS · 2026-08-23
- Somewhat-Bullish 48,096 Shares in CVS Health Corporation $CVS Purchased by Evolve Private Wealth LLC · 2026-08-23
- Bullish Analysis of Cardinal Health Executive Stock Transaction · 2026-08-23
- Somewhat-Bullish Sumitomo Life Insurance Co. Takes $1.56 Million Position in CVS Health Corporation $CVS · 2026-08-22
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)